Shandong Keyuan Pharmaceutical Co., Ltd. (SHE:301281)

China flag China · Delayed Price · Currency is CNY
50.42
-0.57 (-1.12%)
At close: Jul 10, 2026
Market Cap5.46B +49.8%
Revenue (ttm)448.33M +4.6%
Net Income23.54M -62.0%
EPS0.21 -62.9%
Shares Out 108.29M
PE Ratio236.36
Forward PEn/a
Dividend0.05 (0.10%)
Ex-Dividend DateJun 16, 2026
Volume4,229,300
Open50.78
Previous Close50.99
Day's Range49.50 - 52.35
52-Week Range25.87 - 59.24
Beta-0.05
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHE:301281

Shandong Keyuan Pharmaceutical Co., Ltd. is involved in the research and development, manufacture, and marketing of chemical raw materials and their preparations. It offers gliclazide; metformin hydrochloride; isosorbide mononitrate; isosorbide dinitrate; lansoprazole; mecobalamin; ropivacaine hydrochloride; isoflurane; fluoxetine hydrochloride; clarithromycin L-lactate; chlorpheniramine maleate; esmolol hydrochloride; isoproterenol hydrochloride; nicotinamide-tinidazole; aminolevulinate; nisoldipine; qupibutu; propafenone hydrochloride; potass... [Read more]

Sector Healthcare
Founded 2004
Employees 650
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301281
Full Company Profile

Financial Performance

In 2025, SHE:301281's revenue was 398.23 million, a decrease of -14.12% compared to the previous year's 463.72 million. Earnings were 16.55 million, a decrease of -72.62%.

Financial Statements